Georgia's Online Cancer Information Center

Find A Doctor

Nikita Tushar Amin MD
Nikita Tushar Amin MD
Piedmont Cancer Institute
https://www.piedmont.org

Nikita Tushar Amin MD

Specialty
Medical Oncology, Hematology
Trial Cancers
Bile Duct Cancer, Breast Cancer, Esophogeal Cancer, Head and Neck Cancer, Pancreatic Cancer, Stomach/ Gastric Cancer
Affiliations
Piedmont - Atlanta
Piedmont - Fayette
Piedmont - Henry
Piedmont - Newnan
Education

Medical School: Ohio State University

Active Clinical Trial Sites in Georgia

Piedmont Cancer Institute - Atlanta

1800 Howell Mill Road
Suite 800
Atlanta, GA 30318
404-350-9853 (p)
404-350-8407 (f)
www.piedmontcancerinstitute.com

driving directions

Clinical Trials
Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
Cancer Type: Bile Duct Cancer

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Cancer Type: Breast Cancer

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Cancer Type: Breast Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Breast Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Esophogeal Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Head and Neck Cancer

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
Cancer Type: Pancreatic Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Stomach/ Gastric Cancer

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Cancer Type: Unknown Primary


Piedmont Cancer Institute - Newnan

775 Poplar Road
Suite 310
Newnan, GA 30265
770-251-2590 (p)
770-251-1490 (f)
www.piedmontcancerinstitute.com

driving directions

Clinical Trials
Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
Cancer Type: Bile Duct Cancer

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Cancer Type: Breast Cancer

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Cancer Type: Breast Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Breast Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Esophogeal Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Head and Neck Cancer

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
Cancer Type: Pancreatic Cancer

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Cancer Type: Stomach/ Gastric Cancer

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Cancer Type: Unknown Primary


Piedmont Healthcare

2001 Peachtree Road
Suite 645
Atlanta, GA 30309
404-605-2050 (p)
www.piedmont.org/

driving directions

**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.